Skip to main content
lexblog.com/lib/EP7BRSX1viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Sets the Stage for Cures Act Breakthrough Devices Program in Highly Anticipated Guidance Document",
    "url": "https://www.lexblog.com/2017/10/25/fda-sets-the-stage-for-cures-act-breakthrough-devices-program-in-highly-anticipated-guidance-document/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-EP7BRSX1",
        "url": "https://www.lexblog.com/lib/EP7BRSX1/"
    },
    "datePublished": "2017-10-25T13:01:58-04:00",
    "dateModified": "2019-04-30T08:33:10-04:00",
    "author": {
        "@type": "Person",
        "name": "Kevin Madagan, Nicole Aiken-Shaban"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Legal Update",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.lifescienceslegalupdate.com/?p=5334",
    "sourceStability": "may-move"
}